ArticleEuropean journal of heart failure2018

Rationale and design of the ADVOR (Acetazolamide in Decompensated Heart Failure with Volume Overload) trial.

Wilfried Mullens et al.PubMed ↗Publisher ↗

No numbers read from the abstract.